Kronos Worldwide Inc. Announces Board Appointments
June 12, 2012 at 11:01 am
Share
Effective June 8, 2012, Kronos Worldwide Inc's board of directors increased the size of its board from seven to eight and elected Kern Wildenthal, M.D., Ph.D. to fill the newly created vacancy and to serve as a director until his successor is elected and qualified or his earlier resignation, removal or death. The board of directors also appointed Dr. Wildenthal to serve on its audit committee and management development and compensation committee. Since 2008, Dr. Wildenthal has served as president of the Southwestern Medical Foundation. From 1986 to 2008, he served as president of The University of Texas Southwestern Medical Cente.
Kronos Worldwide, Inc. is a global producer and marketer of value-added titanium dioxide pigments, or TiO2, a base industrial product used in a wide range of applications. The Company, along with its distributors and agents, sells and provides technical services for its products. TiO2 is a white inorganic pigment used in applications, such as coatings, plastics and paper, as well as many specialty products such as inks, cosmetics and pharmaceuticals. The Company offers its customers a broad portfolio of products that include over 50 different TiO 2 pigment grades under the KRONOS trademark, which provide a variety of performance properties to meet customers' specific requirements. The Company manufactures and sells iron-based chemicals, which are co-products and processed co-products of the sulfate and chloride process TiO2 pigment production. It also manufactures and sells other specialty chemicals, which are side-stream products from the production of TiO2.
KRONOS WORLDWIDE, INC. 
